BioPorto A/S initiates a rights issue with pre-emptive rights for its existing shareholders and proceeds of up to approximately DKK 59.4 million with approximately DKK 16.6 million pre-subscribed purs

finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Related Keywords

Copenhagen ,Køavn ,Denmark ,United Kingdom ,Boston ,Massachusetts ,United States ,Danish ,Bioportoas Bioporto ,Tim Eriksen ,Arbejdernes Landsbank ,Financial Services ,Company Of The Subscription Price ,Company De Novo ,Drug Administration ,Bioporto Articles Of Association ,Danish Business Authority ,Company Board Of Directors ,Business Update ,Chief Executive Officer ,Additional Information ,Prospectus Regulation ,Central European Time ,Allocation Time ,Pre Emptive Rights ,Existing Share ,New Share ,Subscription Period ,Euronext Securities ,Existing Shares ,Existing Shareholder ,Nasdaq Copenhagen ,New Shares ,Subscription Price ,Danish Business ,Rights Trading Period ,Maximum Subscription ,Remaining Shares ,European Economic Area ,Emptive Rights ,Zenith Advisory ,Acute Kidney Injury ,Member State ,Danish Capital Markets ,Member States ,Qualified Investors ,Markets Act ,Financial Promotion ,Interim Reports ,